454 related articles for article (PubMed ID: 32505000)
1. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
Wang M; Yu F; Chen X; Li P; Wang K
Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
4. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
Hu X; Zhu H; Shen Y; Zhang X; He X; Xu X
Front Oncol; 2021; 11():696705. PubMed ID: 34367979
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
Lin Z; Xie X; Lu S; Liu T
Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
Xia M; Zu X; Chen Z; Wen G; Zhong J
Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.
Lai Y; Huang H; Abudoureyimu M; Lin X; Tian C; Wang T; Chu X; Wang R
Am J Cancer Res; 2020; 10(12):4066-4084. PubMed ID: 33414986
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities.
Subaiea GM; Syed RU; Afsar S; Alhaidan TMS; Alzammay SA; Alrashidi AA; Alrowaili SF; Alshelaly DA; Alenezi AMSRA
Pathol Res Pract; 2024 Jan; 253():155022. PubMed ID: 38086292
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
Front Oncol; 2019; 9():1156. PubMed ID: 31750247
[TBL] [Abstract][Full Text] [Related]
11. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
Fang Y; Zhang X; Huang H; Zeng Z
J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
[TBL] [Abstract][Full Text] [Related]
12. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
Front Immunol; 2022; 13():847728. PubMed ID: 35281015
[TBL] [Abstract][Full Text] [Related]
13. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate.
Arefnezhad R; Ashna S; Rezaei-Tazangi F; Arfazadeh SM; Seyedsalehie SS; Yeganeafrouz S; Aghaei M; Sanandaji M; Davoodi R; Abadi SRK; Vosough M
Cell Biol Int; 2024 May; 48(5):556-576. PubMed ID: 38411312
[TBL] [Abstract][Full Text] [Related]
14. The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.
Ghionescu AV; Sorop A; Dima SO
Front Pharmacol; 2023; 14():1270425. PubMed ID: 37767397
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome sequencing of hepatocellular carcinoma uncovers multiple types of dysregulated ncRNAs.
Zhang L; Wang C; Lu X; Xu X; Shi T; Chen J
Front Oncol; 2022; 12():927524. PubMed ID: 36132143
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma.
Han TS; Hur K; Cho HS; Ban HS
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937886
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer.
Yang S; Sun Z; Zhou Q; Wang W; Wang G; Song J; Li Z; Zhang Z; Chang Y; Xia K; Liu J; Yuan W
Cancer Manag Res; 2018; 10():2249-2257. PubMed ID: 30100756
[TBL] [Abstract][Full Text] [Related]
19. The Crosstalk Between Regulatory Non-Coding RNAs and Nuclear Factor Kappa B in Hepatocellular Carcinoma.
Zhang Y; Shao J; Li S; Liu Y; Zheng M
Front Oncol; 2021; 11():775250. PubMed ID: 34804980
[TBL] [Abstract][Full Text] [Related]
20. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.
Zhou Z; Wang Z; Gao J; Lin Z; Wang Y; Shan P; Li M; Zhou T; Li P
Mol Ther Oncolytics; 2022 Jun; 25():98-120. PubMed ID: 35506150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
